Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: LEO Laboratories Limited, Horizon, Honey Lane, Hurley, Maidenhead, Berkshire, SL6 6RJ, UK
Fucidin 250 mg/5 ml Oral Suspension.
| Pharmaceutical Form |
|---|
|
Suspension for oral administration. Cream coloured suspension with odour of banana. |
Each 5 ml of Suspension contains 250 mg Fusidic Acid, Ph.Eur. (therapeutically equivalent to 175 mg Sodium Fusidate Ph.Eur.).
Excipients with known effect:
Glucose liquid 250 mg/1 ml suspension.
Sorbitol (E420) 100 mg/1 ml suspension.
Sodium 1.6 mg/1 ml suspension.
Orange dry flavour (containing sucrose) 400 mcg/1 ml suspension.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Fusidic acid |
Fusidic acid belongs to a unique group of antibiotics, the fusidanes, which act to inhibit bacterial protein synthesis by blocking the lengthening of factor G. Fusidic acid is active against staphylococcus epidermidis and methicillin resistant staphylococci. |
| List of Excipients |
|---|
|
Acesulfame potassium |
Bottles of 50 ml.
LEO Laboratories Limited, Horizon, Honey Lane, Hurley, Maidenhead, Berkshire, SL6 6RJ, UK
PL 00043/5014R
Date of first authorisation: 11 November 1986
Date of latest renewal: 20 June 2003
| Drug | Countries | |
|---|---|---|
| FUCIDIN | Austria, Australia, Canada, Cyprus, Germany, Ecuador, Estonia, Finland, Hong Kong, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
